ABSTRACT Objective:To analyze the incidence of adverse drug events (ADE) on extract of ginkgo biloba leaves injection. Methods:The CBMDisc, CNKI, VIP, WanFang, PubMed, EMBASE, ClinicalTrials.gov and Cochrane Library were searched using “Extract of Ginkgo Biloba Leaves Injection” or “ginaton” as keywords in September 2016.For studies which met the inclusion criteria, the general and methodology characteristics, intervention information and ADE information were extracted. The ADE incidence of each study was merged using the rate meta analysis. Results:A total of 607 articles were included in the analysis, which includes 716 groups of extract of ginkgo biloba leaves injection. The overall incidence of all ADE was 2.6% (95%CI:2.4%-2.9%). The most common reported ADE was pain at the injection site, the incidence was 7.9% (95%CI:4.9%-12.6%), followed by abdominal distension [7.5% (95%CI:1.2%-36.4%)] and flushing [5.7% (95%CI:3.5%-9.4%)]. 21 ADE case reports including 53 ADEs were analyzed, no patient died or had sequela, all patients recovered completely after drug withdrawal or symptomatic treatment. Conclusion:Many kinds of extract of ginkgo biloba leaves injection ADE were observed, involving multiple body systems, so we should pay more attention to the prevention and treatment of those ADE. Because of the low quality and publication bias of included studies, the findings of our study should be interpreted with caution. |